Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Substance-Related Disorders Clinical Trial

Official title:

Motivational Enhancement Treatment (MET) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00032981
• Other study ID #: NIDA-CTN-0004-1
• Status: Completed
• Phase: Phase 3
• First received: April 5, 2002
• Last updated: January 11, 2017
• Start date: May 2001
• Est. completion date: August 2004

Study information

• Verified date: April 2010
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the therapeutic usefulness of incorporating Motivational Enhancement Treatment into the standard drug abuse treatment entry process of Community Treatment Programs on improving treatment engagement, retention, and outcome.

Description:

Participants seeking treatment at the participating CTPs will be randomly assigned to either "standard" or "MET/MI" treatment, with a 1- and 3-month follow-up. Primary outcome measures will include (1) treatment retention (e.g., number of sessions/weeks completed, the rate of patients completing 3 or more subsequent sessions, and (2) substance use (e.g., urinalyses, days of opioid, cocaine, marijuana, alcohol use, rates of abstinence). Secondary outcomes will include motivation, psychosocial functioning, HIV risk behaviors, treatment utilization, and patient satisfaction. Process assessments will include measures of the working alliance as well as therapist adherence/competence ratings which will evaluate how effectively MET/MI was implemented. Participating CTPs will implement one of two independent protocols, depending on which is the best suited or feasible for the intake procedures at their clinic. Thus, following an invitation to participate, explanation of the study, and provision of informed consent, patients would complete a brief assessment battery followed by either: 1) Random assignment to 3 individual sessions of standard treatment (treatment as usual) at the program versus 3 individual sessions of MET. or 2) Random assignment to 1 individual standard assessment/evaluation session.

Other known NCT identifiers

• NCT00016770

Recruitment information / eligibility

• Status: Completed
• Enrollment: 561
• Est. completion date: August 2004
• Est. primary completion date: August 2004
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

Individuals will be eligible for the protocol who:

• Are seeking outpatient treatment for any substance use disorder

• Are willing to participate in the protocol (e.g., to be randomized to treatment, be contacted for follow-up assessment, to have their sessions audiotaped)

• Are able to understand and provide written informed consent

Exclusion Criteria:

Individuals will be excluded who:

• Are not sufficiently medically or psychiatrically stable to participate in outpatient treatment

• Are seeking detoxification only, methadone maintenance treatment or residential inpatient treatment

Study Design

Allocation: Randomized, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Substance-Related Disorders

Intervention

Behavioral:
• Behavior Therapy

Locations

Country	Name	City	State
United States	CT Renaissance, Inc.	Norwalk	Connecticut
United States	Northeast Treatment Center	Philadelphia	Pennsylvania
United States	Rehab After Work	Philadelphia	Pennsylvania
United States	Haight Ashbury Free Clinics	San Francisco	California
United States	LMG Programs, Inc.	Stamford	Connecticut
United States	Tarzana Treatment Center	Tarzana	California

Sponsors (1)

Lead Sponsor	Collaborator
Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Drug use
Primary	Retention
Primary	HIV risk behaviors
Primary	Psychosocial functioning

External Links

•   Data Elements